Skip to main content
China Resources Pharmaceutical Group Limited logo

China Resources Pharmaceutical Group Limited — Investor Relations & Filings

Ticker · 3320 ISIN · HK0000311099 LEI · 3003004H1KDKMJ8JD874 HKEX Manufacturing
Open in API
Filings indexed 813 across all filing types
Latest filing 2024-06-14 Notice of Dividend Amou…
Country HK Hong Kong
Listing HKEX 3320

About China Resources Pharmaceutical Group Limited

http://www.crpharm.com

China Resources Pharmaceutical Group Limited operates an integrated pharmaceutical value chain encompassing research and development, manufacturing, distribution, and retail of medicines and healthcare products. As an investment holding company, it manages a diverse portfolio focused primarily on the domestic market. Its manufacturing capabilities span multiple therapeutic areas, including chemical drugs, biological drugs, natural medicine, and traditional Chinese medicine. The group leverages its extensive distribution network and retail operations to ensure broad market coverage across China.

Recent filings

Filing Released Lang Actions
DIVIDEND CURRENCY ELECTION FORM FOR THE FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2023
Notice of Dividend Amount Classification · 95% confidence The document is a Dividend Currency Election Form related to the final dividend for the year ended 31 December 2023. It references the announcement dated 26 March 2024 about the final dividend payment and the option for shareholders to elect the currency in which they receive dividends. The document is a form for shareholders to elect their preferred dividend currency (Hong Kong Dollars or Renminbi) and includes instructions on how to complete and submit the form. It does not contain financial statements, management discussion, or detailed financial results. It is not an announcement of dividend amount per se, but a form related to dividend payment options following an already announced dividend. Given the nature of the document as a shareholder form related to dividend payment, it best fits the category of Notice of Dividend Amount (DIV), which includes announcements and related materials about dividend payments and shareholder instructions regarding dividends.
2024-06-14 English
INSIDE INFORMATION THE PROPOSED INTERNAL REORGANIZATION INVOLVING CR SHENGHUO
Capital/Financing Update Classification · 95% confidence The document is an announcement by China Resources Pharmaceutical Group Limited regarding a proposed internal reorganization involving the transfer of shares between subsidiaries. It discusses the board resolution, details of the transaction, valuation by an independent valuer, and implications under the Listing Rules. The document is structured as a formal announcement with no detailed financial statements or comprehensive financial analysis. It is not a full annual or interim report, nor is it a call transcript or audit report. It is not a voting result or remuneration report. The content focuses on a corporate transaction and internal restructuring, which fits best under Capital/Financing Update (CAP) as it relates to changes in the company's capital structure and subsidiary ownership. The document length (8598 characters) and content indicate it is the announcement itself, not a brief notice or a report publication announcement. Therefore, the appropriate classification is CAP with high confidence.
2024-06-11 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information Classification · 95% confidence The document lists the members of the board of directors and their roles and functions, including details about board committees and their memberships. It does not contain financial data, audit results, or any report content. It is a disclosure about board composition and governance structure. This fits the category of Board/Management Information (MANG), which covers announcements of changes or details about the company's board of directors or senior management. The document length is short and focused solely on board information, confirming it is not a full report or announcement of a report publication.
2024-06-07 English
CHANGE OF NON-EXECUTIVE DIRECTOR
Board/Management Information Classification · 100% confidence The document is an announcement from the Board of China Resources Pharmaceutical Group Limited regarding the resignation and appointment of non-executive directors, including details about the individuals involved, their backgrounds, and compliance with regulatory requirements. It does not contain financial data, audit information, or report content. It is clearly a management/board change announcement. Therefore, the appropriate classification is Board/Management Information (MANG). The document length and content confirm it is not a brief notice or a report publication announcement.
2024-06-07 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities' for the month ended 31 May 2024. It details movements in issued shares, share options, and other share capital related information for China Resources Pharmaceutical Group Limited. The document is a regulatory submission to the Hong Kong Exchanges and Clearing Limited, focusing on share capital movements and share options, not a financial report or earnings release. It is a regulatory filing related to share capital movements but does not announce a new share issue or capital change per se, nor is it a report of a share repurchase or director dealing. It is a routine regulatory disclosure of share capital movements under exchange rules. Therefore, the best fitting category is Regulatory Filings (RNS), as it is a general regulatory announcement that does not fit other specific categories like SHA (Share Issue/Capital Change) or POS (Transaction in Own Shares). The document length and content confirm it is not a brief announcement but a detailed regulatory filing.
2024-06-03 English
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 30 MAY 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an announcement of the poll results from the Annual General Meeting (AGM) held on 30 May 2024. It details the voting outcomes on various resolutions including receiving the audited financial statements, re-election of directors, dividend declaration, appointment of auditors, and mandates for share buyback and issuance. The document does not contain the full financial report or detailed financial statements but rather the official voting results of the AGM. It references the Circular for more details and provides links to the company and exchange websites for the full documents. The length is 7,384 characters, which is consistent with a detailed announcement but not a full report. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2024-05-30 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.